| top | |
| BRAINLIFE NEWSLETTER | |
Volume 2, Number 24 - 12
December 2003 |
|
|
|
|
|
Contents |
|
|
|
|
| Etiology & Pathogenesis | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Hemmati HD,
Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M,
Kornblum HI Cancerous stem cells can arise from pediatric brain tumors  Proc Natl Acad Sci U S
A. 2003 Nov 26 |
|
|
|
|
|
|
|
|
|
|
|
M. J. van
den Bent, W. Grisold, D. Frappaz, R.
Stupp, J. P. Desir, T. Lesimple, C.
Dittrich, M. J. A. de Jonge, A. Brandes,
M. Frenay, A. F. Carpentier, P. Chollet,
J. Oliveira, B. Baron, D. Lacombe,
M. Schuessler and P. Fumoleau European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme Annals of Oncology 14:1732-1734, December 2003 (Clinical Study, Abstract) |
|
|
M.
Brada, L. Viviers, C. Abson, F. Hines, J. Britton, S. Ashley, S.
Sardell, D. Traish, A. Gonsalves, P. Wilkins and C. Westbury |
|
|
A. A. Brandes, U. Basso, F. Vastola, A. Tosoni, L. M. Pasetto, A. Jirillo,
S. Lonardi, M. K. Paris, H. Koussis, S. Monfardini and M. Ermani Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study Annals of Oncology 14:1727-1731, December 2003 (Clinical Study, Abstract) |
|
|
Eduardo
Bruera, Larry Driver, Elizabeth A. Barnes, Jie Willey, Loren Shen, J. Lynn
Palmer, Carmelita Escalante Patient-Controlled Methylphenidate for the Management of Fatigue in Patients With Advanced Cancer: A Preliminary Report Journal of Clinical Oncology, Vol 21, Issue 23 (December), 2003: 4439-4443 (Clinical Study, Abstract) |
|
|
H
Cortes-Funes and H Soto Parra Extensive experience of disease control with gefitinib and the role of prognostic markers British Journal of Cancer (December 2003) 89 (Suppl 2), S3-S8. |
|
|
A Katz and P Zalewski Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib British Journal of Cancer (December 2003) 89 (Suppl 2), S15-S18. |
|
|
A. Pace, A. Vidiri, E. Galič, M. Carosi, S. Telera, A. M. Cianciulli,
P. Canalini, D. Giannarelli, B. Jandolo and C. M. Carapella Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Annals of Oncology 14:1722-1726, December 2003 |
|
|
R
Stahel, A Rossi, L Petruzelka, P Kosimidis, F de Braud, M M Bernardo,
P-J Souquet, H Soto Parra and C Gridelli Lessons from the 'Iressa' Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations British Journal of Cancer (December ) 89 (Suppl 2), S19-S23. |
|
|
N
van Zandwijk Tolerability of gefitinib in patients receiving treatment in everyday clinical practice British Journal of Cancer (December ) 89 (Suppl 2), S9-S14. |
|
